MRNA is a kind of nucleic acid molecule that carries genetic information. MRNA vaccine transduces genetic information into the body and produce corresponding antigens, which can induce neutralizing antibodies and stimulate TRead More…
Recently, researchers have found that a Middle East respiratory syndrome coronavirus vaccine has shown efficacy in human trials, which may help to develop a vaccine against the new virus. Professor Marylyn Addo,Read More…
1. Introduction to COVID-19 Novel coronavirus (SARS-CoV-2) is a member of the enveloped RNA virus family, novel coronavirus, which was discovered at the end of 2019. This family of viruses includes MiddleRead More…
Adoptive T cell therapy has achieved clinical success in B cell malignant tumors. However, CAR-T cell therapy is challenged and less effective in patients with solid tumors. A key obstacle is theRead More…
Globally, although the vast majority of people have been vaccinated, more people die from TB than from any other infectious disease. Bacille Calmette-Guerin (BCG) is the only commercially available human tuberculosis vaccine.Read More…
Medical researchers at the University of Texas at Galveston have shown for the first time that a single higher dose of vaccination in a pregnant mouse can safely protect her and herRead More…
Recently, the US Food and Drug Administration (FDA) has approved an application for a supplementary biological product license from Sanofi’s Fluzone® High-Dose Quadrivalent (High dose tetravalent, Influenza Vaccine) for older people agedRead More…
1. RNA vaccine RNA-based vaccines have great potential as a way to treat cancer or prevent a variety of infectious diseases. As a result, many biotechnology companies are now developing this typeRead More…
Janssen Pharmaceutical recently announced that the US Food and Drug Administration (FDA) has awarded the company the breakthrough drug qualification (BTD) for prophylactic RSV advanced vaccines. It is used to prevent lowerRead More…
Recently, Elios Therapeutics released positive top-line data to evaluate the clinical trial of TLPLDC (tumor lysate, particle loading, dendritic cell) vaccine in the treatment of melanoma in phase IIb. 1.Research result ThisRead More…